Justices Urged To Fix 'Novel Misreading' Of IP Safe Harbor

By Dani Kass · October 17, 2024, 7:19 PM EDT

Edwards Lifesciences is asking the U.S. Supreme Court to rein in what's covered under a drug-development safe harbor to avoid patent infringement, saying the Federal Circuit wrongfully expanded it in a "novel...

To view the full article, register now.

Documents

Case Information

Case Title

Edwards Lifesciences Corporation, et al., Petitioners v. Meril Life Sciences Pvt. Ltd., et al.

Case Number

24-428

Court

Supreme Court

Nature of Suit

830 Patent Infringement (Fed. Qst.)

Date Filed

October 16, 2024